MarketsandMarkets Precision Medicine Conference

Harnessing the Potential of Precision Medicine from Bench to Bedside

The healthcare sector is accelerating on a trajectory from ubiquitous treatment to truly personalized treatment. The advent of precision medicine has paved ways for customization and preventive health strategy development by utilizing the genetic information of the individual along with ethnicity, environment exposures, medical history and more. Surging trends in tailoring care have been a driving force for extensive research in this field from data research to target drug discovery.

MarketsandMarkets is delighted to announce its Precision Medicine Conference scheduled to be held on 9th-10th March 2023 in London, UK. The conference is intended to have interactive sessions on precision medicine, application of pharmacogenomics, complex diseases prediction and treatment, technological advancements in diagnosis of diseases, artificial intelligence and bigdata, challenges and ethical considerations in precision medicine.

The event encompasses networking sessions, panel discussions, solutions, and services catering to precision medicine. The conference will bring the full spectrum of experts, leaders, and stakeholders to share a board prospective on opportunities and overcoming the challenges faced during implementation of precision medicine in clinical practice.

Key Highlights

Overview of Precision Medicine and Genomic Science
Precision Medicine in complex disease prediction and treatment – Chronic diseases, CAR T- cell immunotherapy in solid tumors
Comprehensive Genomic profiling - Single cell sequencing using Liquid biopsy, Genetic screening by nextgeneration sequencing and whole genome sequencing
Use of digital biomarkers for drug development, Multi-Omics prospects (Epigenomics, Proteomics, Transcriptomics, Pharmaco genomics)
Inception of technologies for Precision Medicine – Impact of big data, Artificial intelligence, and Machine Learning, Insilico trials for Precision medicine
Cost benefit issues, Regulatory, Ethical and Social challenges in Precision Medicine
Future purview of Precision Medicine, New beginning – Digital health

Why Attend ?

Witness live action how precision medicine is revolutionizing the future of healthcare
Quality insights and cohesiveness of key issues and obstacles experienced by the healthcare providers while implementing precision medicine
Discover the different avenues in patient centric care
Comprehend the current and future regulatory prospects for approval of diagnostic tests
Discuss the emerging technologies and opportunities with cutting edge strategies
Opportunity for one-on-one networking with the delegates and extend professional competency
Panel discussion with great lineup of experts

Who should attend?

Industry: Pharma/Therapeutic Companies/Start Up’s
CEOs, CMO’s, CSO’s, COO’s, Presidents, Vice Presidents, Directors, Managing Directors, Head of Departments, Executive Leaders, Pharmacists, Oncologists, Immunologists, Geneticists, Principal Scientists, Big Data Scientists, Business Development, Regulatory and Policy Advisors, Diagnostic Laboratory Professionals, Global Leaders.
Departments: Oncology, Personalized medicine, Immunology, Molecular Biology, Genetics and genomic medicine, Molecular Medicine, Pharmacogenomics, Biotechnology
Academics: Universities, Research Institutes, Hospitals
Head of Departments, Professors, Lecturers, Senior Scientists, Researchers, Bioinformaticians
Departments: Oncology, Personalized medicine, Immunology, Molecular Biology, Genetics and genomic medicine, Molecular Medicine, Pharmacogenomics, Biotechnology